Amgen is a leading biotechnology company engaged in the discovery, development, manufacture, and delivery of innovative human therapeutics. The company has a strong portfolio of biologic and biosimilar products, and its focus on serious illnesses and unmet medical needs has positioned it as a key player in the biopharmaceutical industry. Amgen's robust pipeline, significant investment in R&D, and strategic acquisitions have bolstered its market position. However, the company faces challenges such as pricing pressures, regulatory hurdles, and competition from other biotech firms. As the healthcare landscape evolves, Amgen has opportunities to expand its product offerings and enter new markets, but it must navigate potential threats such as patent expirations and market access issues.